Source: Zacks

Entasis: Entasis Therapeutics (ETTX) Jumps: Stock Rises 5.4%

Entasis Therapeutics (ETTX) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Manos Perros's photo - President & CEO of Entasis Therapeutics Holdings, Inc.

President & CEO

Manos Perros

CEO Approval Rating

89/100

Entasis is a biotechnology company that develops and commercializes antibiotic therapies for the treatment of bacterial infections. Read more